According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 14 Billion by 2035 at ...

In an era marked by remarkable advancements in medical diagnostics, the global minimal residual disease (MRD) testing market is poised for unprecedented growth. Projections suggest that by 2031, the ...

The North American minimal residual disease (MRD) testing market is poised for substantial growth in the coming years. With a projected annual increase of 11.1% throughout the forecast period, ...

For people with spinal cord injuries/diseases (SCI/D), performing daily tasks can be a challenge due to an impaired ability to grasp and manipulate objects with their hands.